Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
|
16.05.2025 13:57:04
|
Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down, Stock Drops In Pre-market
(RTTNews) - Novo Nordisk A/S (NVO), a healthcare company, on Friday announced that Lars Fruergaard Jørgensen will step down from his role as Chief Executive Officer.
Shares of Novo Nordisk are dropping around 5% in the pre-market trading.
Novo Nordisk Foundation and Novo Holdings A/S Chair Lars Rebien Sørensen will join the Novo Nordisk Board as an observer with the intention of being nominated for election as a board member at the Annual General Meeting in 2026.
Jørgensen will remain as CEO temporarily to ensure a smooth leadership transition. The search for a new CEO is underway.
Lars Rebien Sørensen has pharmaceutical industry expertise from his 16-year tenure as CEO.
In the pre-market trading, 5.37% lesser at $62.60 on the New York Stock Exchange.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
| Novo Nordisk (spons. ADRs) | 57,70 | 0,17% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.